SIGN UP
LOG IN
B
CELG-RT
Bristol-Myers Squibb Company Cel…
0.04
0.01+25.00%Closed15:27 05/21 EDT
OPEN/PREV CLOSE0.0253/0.0320
TODAY RANGE0.0253-0.0400
VOL26.65K
MARKET CAP28.46M
52 WEEK RANGE0.0150-0.1550
AVG VOL (3M)13.08K
% TURNOVER0.00%
TURNOVER--
P/E (TTM)0.0150
% RANGE45.31%
EPS(TTM)2.664
P/E(FORWARD)--
P/B0.0047
BVPS8.55
DIVIDEND--
P/S0.0017
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP28.43M
SHARES OUTSTANDING711.40M
NEXT EARNINGS--
FREE FLOAT710.70M
LOT SIZE1
EX-DIV DATE03/21/2019
News
Press Releases
Financial Reports
Profile
Press release·02/12 21:01
Bristol-Myers Squibb Company Annual Report (Form 10-K) for the fiscal year ended December 31, 2024
Press release·10/31/2024 23:54
Bristol-Myers Squibb Company's Quarterly Report (Form 10-Q)
Press release·07/27/2024 07:30
Bristol-Myers Squibb Company's Quarterly Report (Form 10-Q)
Same Industry
Name/Symbol
Change%
Price
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2025 Webull Securities Limited. All rights reserved.